Related Experiment Video
Updated: Sep 14, 2025

05:51
An In Vitro Model for Studying Tau Aggregation Using Lentiviral-mediated Transduction of Human Neurons
Published on: May 23, 2019
6.0K
Taurine ameliorates viral encephalitis by restoring PRKN-mediated mitophagy
Xiaowei Song1,2,3, Yifei Wang3, Kai Zheng1
1School of Pharmacy, Shenzhen University Medical School, Shenzhen, China.
Autophagy
|July 24, 2025
Summary
Herpes simplex virus type 1 (HSV-1) impairs mitophagy, leading to damaged mitochondria accumulation. Taurine enhances mitophagy, limiting HSV-1 infection and reducing neuroinflammation and encephalitis severity.
Area of Science:
- Cellular biology
- Immunology
- Neuroscience
Background:
- Mitophagy maintains mitochondrial health and regulates antiviral immunity.
- Herpes simplex virus type 1 (HSV-1) infection is known to cause mitochondrial damage, but the underlying mechanisms and implications for viral encephalitis are not fully understood.
Purpose of the Study:
- To investigate the role of mitophagy in HSV-1 infection and viral encephalitis.
- To identify the viral mechanisms that disrupt mitophagy.
- To explore potential therapeutic strategies targeting mitophagy.
Main Methods:
- Investigated mitophagy defects in HSV-1 infected cells and mouse brain tissue.
- Analyzed the effect of viral proteins ICP34.5 and US11 on the EIF2S-ATF4-PRKN axis.
- Assessed the impact of mitophagy modulation on HSV-1 infection, neuroinflammation, and encephalitis severity.
- Examined the effect of taurine on mitophagy and HSV-1 infection.
Main Results:
- HSV-1 infection leads to damaged mitochondria accumulation due to defective mitophagy.
- Viral proteins ICP34.5 and US11 suppress PRKN expression by inhibiting the EIF2S-ATF4 axis, impeding mitophagy.
- Modulating mitophagy affects HSV-1 infection, NF-κB-mediated neuroinflammation, and encephalitis severity.
- Taurine promotes PRKN-mediated mitophagy, limiting HSV-1 infection in vitro and in vivo.
Conclusions:
- Mitophagy plays a protective role in restricting viral encephalitis.
- The ATF4-PRKN axis is a key regulator of mitophagy during HSV-1 infection.
- Targeting the ATF4-PRKN axis offers a potential therapeutic strategy for neurotropic virus-related diseases.

